In brief
- The EU and the UK are increasingly viewing medical technologies and biotechnology as integral components of their security and defense strategies, both military and civilian, bringing life sciences regulation into direct contact with defense and aerospace frameworks.
- For most products, the standard EU and UK life sciences framework

